Space-based emergency medical services market to reach $2.75 billion by 2030 at 14.1% CAGR, driven by increasing investments in space activities and development of advanced telemedicine systems.
Read More
Space-based biopharmaceuticals market to reach $8.12 billion by 2030 at 11.3% CAGR, driven by growing demand for advanced therapeutics and innovation enabled by microgravity-based drug development.
Read More
Space medicine market to reach $2.4 billion by 2030 at 12.5% CAGR, driven by increasing interest in space tourism and rising need for advanced health monitoring and preventive care for civilians.
Read More
Sotorasib tablets market to reach $3.4 billion by 2030 at 12.0% CAGR, driven by rising prevalence of cancer and growing geriatric population requiring precision therapies for kras-mutated tumors.
Read More
Sorafenib market to reach $1.56 billion by 2030 at 3.9% CAGR, driven by increasing prevalence of cancer and rising healthcare expenditure supporting access to targeted oncology therapies.
Read More
Somatic genetic testing market to reach $14.92 billion by 2030 at 13.9% CAGR, driven by increasing incidence of cancer & growing use of tumor-specific mutation detection for personalized treatments.
Read More
Softgel capsules market to reach $13.52 billion by 2030 at 8.9% CAGR, driven by rising prevalence of chronic ailments and increasing demand for nutritional supplements.
Read More
Soft mist inhalers market to reach $4.48 billion by 2030 at 7.9% CAGR, driven by rising incidence of asthma and growing demand for efficient, patient-friendly respiratory drug delivery systems.
Read More
Sodium hyaluronate-based products market to reach $18.19 billion by 2030 at 9.6% CAGR, driven by rising focus on skin hydration, elasticity, and aesthetic enhancement.
Read More
SNP genotyping and analysis market to reach $46.29 billion by 2030 at 20.1% CAGR, driven by growing burden of genetic diseases & increasing adoption of genetic variation analysis for early diagnosis.
Read More